Advertisement

Serum SUR1 and TRPM4 in patients with subarachnoid hemorrhage

  • Tolga Turan DundarEmail author
  • Anas Abdallah
  • Ismail Yurtsever
  • Eray Metin Guler
  • Omer Faruk Ozer
  • Omer Uysal
Original Article
  • 37 Downloads

Abstract

Neuroinflammation plays an important role in neuronal injury after aneurysmal subarachnoid hemorrhage (aSAH). Sulfonylurea receptor 1 (SUR1) and transient receptor potential cation channel subfamily M member 4 (TRPM4) receptors play an important role in the pathogenesis of several neural injuries, such as neural edema, spinal cord damage, stroke, and neuronal damage in aSAH. This study aimed to investigate the relationship of serum SUR1 and TRPM4 levels with the neurological status within the first 15 days after aSAH. In this prospective study, blood samples were collected from 44 consecutive patients on the 1st, 4th, and 14th days after aSAH. Serum SUR1 and TRPM4 levels were measured using an enzyme-linked immunosorbent assay kit. Glasgow coma scale and World Federation of Neurosurgical Societies (WFNS) scores upon presentation and Glasgow outcome scale (GOS) score on the 14th day were recorded. Serum SUR1 and TRPM4 levels on the 1st, 4th, and 14th days were significantly higher in patients with aSAH than in normal individuals. This increase in the levels varied among the 1st, 4th, and 14th days. On the first day, a correlation was observed between serum SUR1, but not TRPM4, levels and the WFNS score. Moreover, on the 14th day, an association of serum SUR1 and TRPM4 levels with the GOS score was noted. Serum SUR1 and TRPM4 levels were significantly upregulated in the peripheral blood samples. Further study is warranted to establish the utility of SUR1 and TRPM4 as biomarkers in patients with aSAH.

Keywords

Aneurysmal subarachnoid hemorrhage SUR1 TRPM4 Neurological status Prognosis Treatment 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This prospective study was approved by Bezmialem Vakif University ethical board under decision no. 2018.876.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Abdallah A, Asiltürk M, Emel E, Güler Abdallah B (2018) Factors affecting the outcome of multiple intracranial aneurysm surgery. Indian J Neurosurg 7(2):116–121CrossRefGoogle Scholar
  2. 2.
    Asiltürk M, Abdallah A (2018) Clinical outcomes of multiple aneurysms microsurgical clipping: evaluation of 90 patients. Neurol Neurochir Pol 52(1):15–24CrossRefGoogle Scholar
  3. 3.
    Bailes JE, Spetzler RF, Hadley MN, Baldwin HZ (1990) Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg 72:559–566CrossRefGoogle Scholar
  4. 4.
    Caffes N, Kurland DB, Gerzanich V, Simard JM (2015) Glibenclamide for the treatment of ischemic and hemorrhagic stroke. Int J Mol Sci 16(3):4973–4984CrossRefGoogle Scholar
  5. 5.
    Chalouhi N, Ali MS, Jabbour PM et al (2012) Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab 32(9):1659–1676CrossRefGoogle Scholar
  6. 6.
    Dündar TT, Aralaşmak A, Özdemir H et al (2018) Comparison of TOF MRA, contrast-enhanced MRA and subtracted CTA from CTP in residue evaluation of treated intracranial aneurysms. Turk Neurosurg 28(4):563–570Google Scholar
  7. 7.
    Fung C, Inglin F, Murek M et al (2016) Reconsidering the logic of World Federation of Neurosurgical Societies grading in patients with severe subarachnoid hemorrhage. J Neurosurg 124(2):299–304CrossRefGoogle Scholar
  8. 8.
    Gerzanich V, Kwon MS, Woo SK, Ivanov A, Simard JM (2018) SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells. PLoS One 13(4):1–23CrossRefGoogle Scholar
  9. 9.
    Gotoh O, Tamura A, Yasui N, Suzuki A, Hadeishi H, Sano K (1996) Glasgow Coma Scale in the prediction of outcome after early aneurysm surgery. Neurosurgery 39(1):19–25CrossRefGoogle Scholar
  10. 10.
    Grasso G, Alafaci C, Macdonald RL (2017) Management of aneurysmal subarachnoid hemorrhage: state of the art and future perspectives. Surg Neurol Int 8:11CrossRefGoogle Scholar
  11. 11.
    Haug T, Sorteberg A, Finset A, Lindegaard KF, Lundar T, Sorteberg W (2010) Cognitive functioning and health-related quality of life 1 year after aneurysmal subarachnoid hemorrhage in preoperative comatose patients (Hunt and Hess Grade V patients). Neurosurgery 66:475–485CrossRefGoogle Scholar
  12. 12.
    Ironside N, Buell TJ, Chen CJ et al (2019) High-grade aneurysmal subarachnoid hemorrhage: predictors of functional outcome. World Neurosurg:e723–e728Google Scholar
  13. 13.
    Kurland DB, Tosun C, Pampori A et al (2013) Glibenclamide for the treatment of acute CNS injury. Pharmaceuticals (Basel) 6(10):1287–1303CrossRefGoogle Scholar
  14. 14.
    Le Roux PD, Elliott JP, Newell DW, Grady MS, Winn HR (1996) Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg 85:39–49CrossRefGoogle Scholar
  15. 15.
    Lucke-Wold BP, Logsdon AF, Manoranjan B et al (2016) Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review. Int J Mol Sci 17:497–509CrossRefGoogle Scholar
  16. 16.
    Navratil O, Duris K, Juran V, Neuman E, Svoboda K, Smrcka M (2017) Middle cerebral artery aneurysms with intracerebral hematoma—the impact of side and volume on final outcome. Acta Neurochir 159(3):543–547CrossRefGoogle Scholar
  17. 17.
    Oliveira AM, Paiva WS, Figueiredo EG, Oliveira HA, Teixeira MJ (2011) Fisher revised scale for assessment of prognosis in patients with subarachnoid hemorrhage. Arq Neuropsiquiatr 69(6):910–913CrossRefGoogle Scholar
  18. 18.
    Scharbrodt W, Stein M, Schreiber V, Böker DK, Oertel MF (2009) The prediction of long-term outcome after subarachnoid hemorrhage as measured by the Short Form-36 Health Survey. J Clin Neurosci 16(11):1409–1413CrossRefGoogle Scholar
  19. 19.
    Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, Melnichenko L, Gerzanich V (2009) Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab 29(2):317–330CrossRefGoogle Scholar
  20. 20.
    Simard JM, Kahle KT, Gerzanich V (2010) Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4. J Neurosurg 113:622–629CrossRefGoogle Scholar
  21. 21.
    Tosun C, Kurland DB, Mehta R, Castellani RJ, deJong J, Kwon MS, Woo SK, Gerzanich V, Simard JM (2013) Inhibition of the SUR1-TRPM4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke. 44(12):3522–3528CrossRefGoogle Scholar
  22. 22.
    Woo SK, Kwon MS, Ivanov A, Gerzanich V, Simard JM (2013) The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. J Biol Chem 288:3655–3667CrossRefGoogle Scholar
  23. 23.
    Wostrack M, Sandow N, Vajkoczy P, Schatlo B, Bijlenga P, Schaller K, Kehl V, Harmening K, Ringel F, Ryang YM, Friedrich B, Stoffel M, Meyer B (2013) Subarachnoid haemorrhage WFNS grade V: is maximal treatment worthwhile? Acta Neurochir 155:579–586CrossRefGoogle Scholar
  24. 24.
    Zhang G, Lin X, Zhang S, Xiu H, Pan C, Cui W (2017) A protective role of Glibenclamide in inflammation-associated injury Mediators Inflamm Article ID: 3578702, 11 pagesGoogle Scholar
  25. 25.
    Zhang Y, Hu Q, Xue H et al (2017) Intrasylvian/intracerebral hematomas associated with ruptured middle cerebral artery aneurysms: a single-center series and literature review. World Neurosurg 98:432–437CrossRefGoogle Scholar
  26. 26.
    Zhao C, Wei Y (2017) Surgical timing for aneurysmal subarachnoid hemorrhage: A meta-analysis and systematic review. Turk Neurosurg 27(4):489–499PubMedGoogle Scholar
  27. 27.
    Zheng VZ, Wong GKC (2017) Neuroinflammation responses after subarachnoid hemorrhage: a review. J Clin Neurosci 42:7–11CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of NeurosurgeryBezmialem Vakif UniversityFatihTurkey
  2. 2.Department of RadiologyBezmialem Vakif UniversityIstanbulTurkey
  3. 3.Department of BiochemistryBezmialem Vakif UniversityIstanbulTurkey
  4. 4.Department of BiostatisticsBezmialem Vakif UniversityIstanbulTurkey

Personalised recommendations